5-161364629-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001371727.1(GABRB2):c.542-27860G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 151,970 control chromosomes in the GnomAD database, including 2,916 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.17 ( 2916 hom., cov: 32)
Consequence
GABRB2
NM_001371727.1 intron
NM_001371727.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.167
Publications
3 publications found
Genes affected
GABRB2 (HGNC:4082): (gamma-aminobutyric acid type A receptor subunit beta2) The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 2 subunit. It is mapped to chromosome 5q34 in a cluster comprised of genes encoding alpha 1 and gamma 2 subunits of the GABA A receptor. Alternative splicing of this gene generates 2 transcript variants, differing by a 114 bp insertion. [provided by RefSeq, Jul 2008]
GABRB2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy 92Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.311 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRB2 | NM_001371727.1 | c.542-27860G>A | intron_variant | Intron 5 of 9 | ENST00000393959.6 | NP_001358656.1 | ||
GABRB2 | NM_021911.3 | c.542-27860G>A | intron_variant | Intron 6 of 10 | NP_068711.1 | |||
GABRB2 | NM_000813.3 | c.542-27860G>A | intron_variant | Intron 6 of 9 | NP_000804.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.167 AC: 25318AN: 151852Hom.: 2908 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25318
AN:
151852
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.167 AC: 25346AN: 151970Hom.: 2916 Cov.: 32 AF XY: 0.168 AC XY: 12506AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
25346
AN:
151970
Hom.:
Cov.:
32
AF XY:
AC XY:
12506
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
13055
AN:
41436
American (AMR)
AF:
AC:
2124
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
352
AN:
3466
East Asian (EAS)
AF:
AC:
1097
AN:
5168
South Asian (SAS)
AF:
AC:
311
AN:
4814
European-Finnish (FIN)
AF:
AC:
1854
AN:
10556
Middle Eastern (MID)
AF:
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5985
AN:
67942
Other (OTH)
AF:
AC:
371
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
971
1942
2913
3884
4855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
502
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.